SCHEMBL23035261

SCHEMBL23035261

N=C(N=C(N)N1CCCCC1)Nc1cccc(F)c1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.57
NPC1 O15118 4/20 0.51
RAB9A P51151 4/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
NFKB1 P19838 1/20 0.51
MAPK1 P28482 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
MAPT P10636 1/20 0.49
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
SIGMAR1 Q99720 1/20 0.41
CYP3A4 P08684 2/20 0.41
IDO1 P14902 1/20 0.41
CASP3 P42574 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
GAA P10253 1/20 0.41
USP2 O75604 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23035300 0.99 ALDH1A1 (0.56) ALDH1A1NPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL23035258 0.86 ALDH1A1 (0.38) ALDH1A1NPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL23035179 0.85 KMT2A (0.45) ALDH1A1RAB9AMAPTMEN1KMT2A
SCHEMBL23035241 0.85 DDX3X (0.43) ALDH1A1NPC1RAB9AMEN1KMT2A
Hydrochloric Acid SCHEMBL23035266 0.85 NPC1 (0.38) ALDH1A1NPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL23035238 0.84 SMN1; SMN2 (0.48) ALDH1A1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL23035229 0.84 ALDH1A1 (0.59) ALDH1A1RAB9AMEN1KMT2ASIGMAR1
Hydrochloric Acid SCHEMBL23035228 0.84 KMT2A (0.44) ALDH1A1RAB9AMAPTMEN1KMT2A
SCHEMBL23035236 0.84 ALDH1A1 (0.57) ALDH1A1NPC1RAB9AMAPTMEN1
SCHEMBL23035283 0.84 ALDH1A1 (0.57) ALDH1A1NPC1RAB9AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2742019-B1 N1-CYCLIC AMINE-N5-SUBSTITUTED PHENYL BIGUANIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME IMMUNOMET THERAPEUTICS INC (US) 2021-03-03 EP claimed
CN-103827083-B N1-cyclammonium-N5-substituted-phenyl Biguanide derivative and preparation method thereof and the pharmaceutical composition containing this derivative IMMUNOMET THERAPEUTICS INC. (US) 2016-03-09 CN claimed
EP-2742019-B1 N1-CYCLIC AMINE-N5-SUBSTITUTED PHENYL BIGUANIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME IMMUNOMET THERAPEUTICS INC (US) 2021-03-03 EP disclosed